Contact Surface and Hand Disinfection – Applying Pharma’s Disinfectant Efficacy Concepts for COVID-19

Contact Surface and Hand Disinfection – Applying Pharma’s Disinfectant Efficacy Concepts for COVID-19

By Tracy TreDenick-Fricke, BioTechLogic, Head of Regulatory and Quality, and Senior Consultant Most of us now understand that SARS-CoV-2 (the cause of COVID-19) is often transmitted via respiratory droplets. However, SARS-CoV-2 is also spread by contaminated contact surfaces and hands, but all contact surfaces are not created equally. A chart published by the Journal of Hospital Infection is quite helpful for understanding the persistence of the virus on various surfaces.

The Evolution of Therapeutic Monoclonal Antibodies

The Evolution of Therapeutic Monoclonal Antibodies

By Tracy TreDenick, Head of Regulatory and Quality, and Senior Consultant, BioTechLogic The elegant simplicity of monoclonal antibodies (mAbs) has catapulted them to a starring role within the world of precision medicine over the course of the last couple of decades....
Gene Therapy for Rare Disorders Becoming Viable

Gene Therapy for Rare Disorders Becoming Viable

Resurgent across the biomedical engineering and clinical trial landscape, gene therapy owes its new vitality to a better understanding of rare diseases, the discovery of new gene delivery vectors, and the development of site-specific genome editing technology. Already...
Six Fascinating Life Sciences AI Applications

Six Fascinating Life Sciences AI Applications

Where is life sciences AI heading? More is better when it comes to Big Data and machine learning. This is particularly true in the fields of medicine and pharma. A report by Accenture estimates that by the year 2026, Big Data in conjunction with machine learning in...